Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
12/2000
12/21/2000CA2376630A1 Induction of vascular endothelial growth factor (vegf) by the serine/threonine protein kinase akt
12/21/2000CA2376523A1 Dna pcv-vaccine
12/21/2000CA2376421A1 Identification and molecular characterisation of proteins, expressed in the tick salivary glands
12/21/2000CA2376389A1 Cloning and expression of a novel 5-ht4 receptor
12/21/2000CA2376288A1 Use of antibodies against cd20 for the treatment of the graft versus host disease
12/21/2000CA2375924A1 Compositions and methods for detecting treponema pallidum
12/21/2000CA2375619A1 Equine granulocyte-macrophage colony-stimulating factor (gm-csf)
12/21/2000CA2375560A1 Manufacturing method for intravenous immune globulin and resultant product
12/21/2000CA2375346A1 Fibrin sealant as a transfection/transformation vehicle for gene therapy
12/21/2000CA2375320A1 Dna vaccines for pets or for animals used in sports
12/20/2000EP1061129A1 Infectious retroviruses from a leukemic dog cell line with extensive homologies to murine leukemia viruses
12/20/2000EP1060259A2 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs
12/20/2000EP1060254A2 Human proteinase molecules
12/20/2000EP1060251A2 Phosphodiesterase 10
12/20/2000EP1060247A1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response
12/20/2000EP1060193A2 Cd147 binding molecules as therapeutics
12/20/2000EP1059937A2 Il-12 enhancement of immune responses to t-independent antigens
12/20/2000EP1059936A1 Il-12 stimulation of neonatal immunity
12/20/2000EP1059935A1 Mucosal microparticle conjugate vaccine
12/20/2000EP1059929A2 Isolated stromal cells for use in the treatment of diseases of the central nervous system
12/20/2000EP0762875B1 Microparticle delivery system
12/20/2000CN1277616A Peptides capable of inhibiting the interaction between presenilins and the beta-amyloid peptide or its precursor
12/20/2000CN1277614A Mammaglobin a secreted mammary-specific breast cancer protein
12/20/2000CN1277556A Application of TNF antagonists as medicaments for treating septic diseases
12/20/2000CN1277551A Biphasic lipid vesicle composition for transdermal administration of an immunogen
12/20/2000CN1277549A Vesicular complexes and methods of making and using the same
12/20/2000CN1277261A Animal's castration vaccine gene and gene engineering body
12/20/2000CN1059705C Composition for introducing nucleic acid complexes into higher eucaryotic cells
12/20/2000CN1059701C Donkey leukocyte hypotoxic strain for equine infection anemia and its culture method
12/20/2000CN1059599C 蛙病毒疫苗 Frog virus vaccine
12/20/2000CN1059598C Preparation of fulminant infectious disease bigeminy vaccine of freshwater fishes
12/19/2000US6162638 Attenuated strains of leishmania and uses thereof
12/19/2000US6162631 Retrovirus from the HIV group and its use (MVP-2901/94)
12/19/2000US6162625 Phenylalanyl tRNA synthetase from streptococcus pneumoniae
12/19/2000US6162620 Nucleotide sequences coding human cytomegalo viral polypeptides; for the development of preventative against human cytomegalo viral infection
12/19/2000US6162600 Indications for the use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses
12/19/2000US6162461 Chicken anemia virus mutants and vaccines and uses based on the viral proteins VP1, VP2 and VP3 or sequences of that virus coding therefor
12/19/2000US6162440 Variant competes with ebna2 protein for cbf1, a cellular dna-binding protein; ebna2 is a transcriptional activator that regulates viral latency gene expression and activates expression of cellular genes; suppressing epstein-barr virus
12/19/2000US6162439 An isolated polypeptides derived from novel lentiviruses for the detection of aids
12/19/2000US6162436 Compositions and methods using complexes of heat shock protein 90 and antigenic molecules for the treatment and prevention of neoplastic diseases
12/19/2000US6162435 A isolated protein for treating swine; a diagnostic test kit for detecting the presence of bacterial infection in swine herds
12/19/2000US6162433 A transformed cell which is an attenuated strain of its natural counterpart, can be engineered to express at least one antigen and at least one safe, selectable marker
12/19/2000US6162429 Biologically pure serpens spp. strain hbl-112 (atcc 202005); treating infectious disease of the feet and/or lower legs of cattle
12/19/2000CA2145881C Anti-inflammatory, tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides
12/19/2000CA2067244C Monoclonal antibody specific for iga receptor
12/19/2000CA2053206C Monoclonal antibodies against melanoma
12/19/2000CA2000420C Peptides representing epitopic sites on r-ifn-beta, antibodies thereto, and uses thereof
12/14/2000WO2000075665A1 Early detection of flaviviruses using the ns1 glycoprotein
12/14/2000WO2000075659A1 Antibodies to nucleus pulposus in disc herniation, diagnostic kit, medical preparations and treatment
12/14/2000WO2000075352A2 Hcv/bvdv chimeric genomes and uses thereof
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075345A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof
12/14/2000WO2000075342A1 Novel plasmid vector
12/14/2000WO2000075338A2 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
12/14/2000WO2000075336A2 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075304A1 Immunostimulant oligonucleotide
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075191A2 Apo-2L RECEPTOR AGONIST AND CPT-11 SYNERGISM
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075181A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000WO2000075180A2 Peptides for vaccinating against human cmv
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075126A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000WO2000074729A2 Alpha or beta emitters to fragments in radioimmunotherapy
12/14/2000WO2000074722A2 Modification of biological elements
12/14/2000WO2000074719A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
12/14/2000WO2000074718A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/14/2000WO2000074717A1 NOVEL Ig FRACTIONS HAVING AN IMMUNOMODULATORY ACTIVITY
12/14/2000WO2000074716A2 Ige peptides for allergy immunotherapy
12/14/2000WO2000074715A1 Methods and compounds for the treatment of immunologically-mediated diseases using mycobacterium vaccae
12/14/2000WO2000074714A2 Indicators for monitoring the technique of transcutaneous immunization
12/14/2000WO2000074706A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000WO2000074634A2 Methods and compositions for modulating cell proliferation and cell death
12/14/2000WO2000074630A2 Dna vaccine for protecting an avian against infectious bursal disease virus
12/14/2000WO2000050562A3 Dna encoding snorf25 receptor
12/14/2000WO2000048681A3 Co-administration of a thrombolytic and an anti-cd18 antibody
12/14/2000WO2000048615A3 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE)
12/14/2000WO2000047229A3 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
12/14/2000WO2000047225A3 Tuberculosis vaccine formulation comprising monoglycerides or fatty acids as adjuvant
12/14/2000WO2000047224A3 Vaccine formulation comprising monoglycerides or fatty acids as adjuvant
12/14/2000WO2000045841A3 Human papilloma virus vaccine formulations
12/14/2000WO2000045770A3 Compressed lecithin preparations
12/14/2000WO2000043032A3 Baff, inhibitors thereof and their use in the modulation of b-cell response
12/14/2000WO2000033872A9 Method of and compositions for immunization with the pseudomonas v antigen
12/14/2000CA2504679A1 Compositions and methods for the treatment of tumor
12/14/2000CA2501815A1 Compositions and methods for the treatment of tumor
12/14/2000CA2377385A1 Methods and compositions for modulating cell proliferation and cell death
12/14/2000CA2376634A1 Immunostimulant oligonucleotide
12/14/2000CA2376335A1 Novel ig fractions having an immunomodulatory activity
12/14/2000CA2376210A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway
12/14/2000CA2376192A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000CA2376179A1 Method of treating carcinoma using antibody therapy and ameliorating side effects associated with such therapy
12/14/2000CA2376078A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000CA2376010A1 Mycolactone and related compounds, compositions and methods of use
12/14/2000CA2375912A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells
1 ... 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 ... 1823